COMP <GO>
PODD vs GMED // RSI-14 & 200D SMA MOMENTUM
Insulet Corporation (NASDAQ) VS. Globus Medical Inc. (NYSE) • 15-METRIC TALLY: PODD 6
— GMED 7
▲ RSI-14 & 200D SMA MOMENTUM LEADER: PODD
LAST: $152.50 (+2.40%) • MKT CAP: $10.58B
rsi-technicals
66.0
LAST: $82.91 (+2.03%) • MKT CAP: $11.13B
rsi-technicals
59.8
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PODD VS. GMED)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PODD | GMED | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 71.60% | 67.40% | +4.20 | PODD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.40% | 8.70% | +11.70 | PODD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.1x | 17.6x | -0.50 | PODD | /valuation <GO> |
| Free Cash Flow Yield | 3.57% | 5.29% | -1.72 | GMED | /fcf-yield <GO> |
| Operating Margin | 17.50% | 16.30% | +1.20 | PODD | /operating-margins <GO> |
| Net Profit Margin | 9.10% | 18.30% | -9.20 | GMED | /net-margins <GO> |
| Revenue Growth (YoY) | 30.70% | 16.70% | +14.00 | PODD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.72 | 10.74 | -5.02 | GMED | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | GMED | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 66.0 | 59.8 | +6.20 | PODD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 1.07 | -0.08 | GMED | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.0x | 17.4x | +18.60 | GMED | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.58B | $11.13B | -$555.1M | GMED | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PODD REV | GMED REV | PODD GROSS % | GMED GROSS % | PODD FCF | GMED FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.71B | $2.94B | 71.6% | 67.4% | $377.7M | $588.8M |
| FY 2024 | $2.07B | $2.52B | 69.8% | 58.9% | $305.3M | $405.2M |
| FY 2023 | $1.70B | $1.57B | — | — | $69.3M | $172.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PODD // BETA 0.99
GMED // BETA 1.07